Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,120 | 218 | 97.7% |
| Education | $96.50 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $872.75 | 38 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $745.29 | 40 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $726.14 | 34 | $0 (2024) |
| ABBVIE INC. | $371.40 | 28 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $192.51 | 7 | $0 (2023) |
| Shire North American Group Inc | $188.28 | 10 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $179.27 | 9 | $0 (2023) |
| ITI, Inc. | $178.85 | 7 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $173.78 | 11 | $0 (2024) |
| Lundbeck LLC | $151.12 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.54 | 4 | ABBVIE INC. ($28.45) |
| 2023 | $197.53 | 8 | ITI, Inc. ($48.28) |
| 2022 | $501.29 | 30 | ABBVIE INC. ($191.40) |
| 2021 | $463.69 | 24 | Teva Pharmaceuticals USA, Inc. ($152.45) |
| 2020 | $294.85 | 11 | Allergan, Inc. ($183.84) |
| 2019 | $1,165 | 58 | Sunovion Pharmaceuticals Inc. ($326.87) |
| 2018 | $784.63 | 45 | Otsuka America Pharmaceutical, Inc. ($307.66) |
| 2017 | $710.99 | 39 | Sunovion Pharmaceuticals Inc. ($219.46) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: PSYCHIATRY | ||||||
| 02/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: PSYCHIATRY | ||||||
| 02/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: PSYCHIATRY | ||||||
| 02/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: PSYCHIATRY | ||||||
| 02/20/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Central Nervous System | ||||||
| 02/16/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 02/15/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: PSYCHIATRY | ||||||
| 02/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: PSYCHOLOGY | ||||||
| 11/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2022 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/01/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CNS | ||||||
| 11/01/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/31/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/27/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: PSYCHIATRY | ||||||
| 08/25/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: CNS | ||||||
About Paul Homsy, M.D., M.P.H
Paul Homsy, M.D., M.P.H is a Psychiatry healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801899455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paul Homsy, M.D., M.P.H has received a total of $4,217 in payments from pharmaceutical and medical device companies, with $98.54 received in 2024. These payments were reported across 219 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,120).
Practice Information
- Specialty Psychiatry
- Location Houston, TX
- Active Since 05/27/2005
- Last Updated 02/27/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801899455
Products in Payments
- VRAYLAR (Drug) $1,054
- LATUDA (Drug) $745.29
- REXULTI (Drug) $531.71
- ABILIFY MAINTENA (Drug) $229.30
- TRINTELLIX (Drug) $203.86
- CAPLYTA (Drug) $202.68
- NAMENDA XR (Drug) $143.45
- VYVANSE (Drug) $137.30
- Fanapt (Drug) $115.42
- AUSTEDO (Drug) $96.01
- Trintellix (Drug) $91.76
- MYDAYIS (Drug) $77.13
- Dayvigo (Drug) $68.24
- BELSOMRA (Drug) $62.84
- INVEGA TRINZA (Drug) $56.58
- HETLIOZ (Drug) $42.99
- SPRAVATO (Drug) $37.96
- NAMZARIC (Drug) $34.25
- APLENZIN (Drug) $32.93
- GRALISE (Drug) $28.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Houston
Dr. Lawrence Ginsberg, M.d, M.D
Psychiatry — Payments: $1.1M
Dr. Mazhar Khowaja
Psychiatry — Payments: $897,870
Barry Gritz, M.d, M.D
Psychiatry — Payments: $731,949
Dr. Frank Chen, Md Pa, MD PA
Psychiatry — Payments: $721,138
Dr. Aaron Peterson, Do, DO
Psychiatry — Payments: $549,804
Ayesha Rashid, M.d, M.D
Psychiatry — Payments: $445,948